bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 92.65
+0.85 (0.93%)
Apr 1, 2026, 9:44 AM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €10.83 billion as of March 31, 2026. Its market cap has decreased by -20.76% in one year.
Market Cap
10.83B
Enterprise Value
10.72B
Revenue
4.07B
Ranking
n/a
PE Ratio
27.49
Stock Price
€92.65
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 10.83B, an increase of 814.84%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 10.79B | -17.17% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 98.90B |
| EssilorLuxottica Société anonyme | 89.91B |
| Sartorius Stedim Biotech | 16.05B |
| Ipsen | 12.81B |
| Eurofins Scientific SE | 11.03B |
| ABIVAX Société Anonyme | 7.06B |
| Virbac | 2.95B |
| emeis Société anonyme | 2.00B |